Ikena Oncology, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 16.15 million compared to USD 14.22 million a year ago. Basic loss per share from continuing operations was USD 0.33 compared to USD 0.39 a year ago.
Market Closed -
Other stock markets
|
After market 05:07:48 pm | |||
1.67 USD | +25.56% | 1.65 | -1.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.23% | 64.18M | |
+48.67% | 58.71B | |
-2.76% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.25% | 26.55B | |
-23.10% | 18.98B | |
+1.88% | 12.51B | |
+26.43% | 12.08B | |
+21.74% | 11.94B |
- Stock Market
- Equities
- IKNA Stock
- News Ikena Oncology, Inc.
- Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024